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Progressive multifocal leukoencephalopathy (PML) is a
disease of the central nervous system caused by JC virus
infection. As a general rule PML patients suffer from an
acquired or congenital immune deficiency syndrome.
Here we present the history of a 78-year-old female
patient who was treated with corticosteroids (25–75 mg
Prednisolone) for suspected pulmonary sarcoidosis. The
patient developed an acute brachio-facial hemiparesis.
The cerebral imaging showed focal demyelination but an
analysis of the cerebrospinal fluid did not point towards
an inflammatory cause of these alterations. Assuming a
cerebral manifestiation of the pre-diagnosed sarcoidosis,
the dose of the glucocorticosteroids was increased. Soon
after admission, the patient's pulmonary capacity deterio-
rated sharply and she required intubation with artificial
ventilator therapy. She subsequently died due to compli-
cating fungal pneumonia. While pathological findings
could confirm the diagnosis of pulmonary aspergillosis,
the neuropathological workup surprisingly revealed PML
as the underlying reason for her neurological symptoms.
This unfavourable disease course highlights that even
short-term immunosuppression with routine dosages of
glucocorticosteroids may lead to PML, despite the lack of
indicative clues in the CSF.
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